(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 79.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.67%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Invivyd's revenue in 2025 is $46,210,000.On average, 1 Wall Street analysts forecast IVVD's revenue for 2025 to be $7,040,368,725, with the lowest IVVD revenue forecast at $7,040,368,725, and the highest IVVD revenue forecast at $7,040,368,725. On average, 1 Wall Street analysts forecast IVVD's revenue for 2026 to be $15,486,408,338, with the lowest IVVD revenue forecast at $15,486,408,338, and the highest IVVD revenue forecast at $15,486,408,338.
In 2027, IVVD is forecast to generate $33,688,044,204 in revenue, with the lowest revenue forecast at $33,688,044,204 and the highest revenue forecast at $33,688,044,204.